Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests.
about
Interaction of daptomycin with lipid bilayers: a lipid extracting effectIn vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centersDaptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin.Antimicrobial susceptibilities and molecular epidemiology of clinical isolates of Clostridium difficile in taiwan.Baseline study to determine in vitro activities of daptomycin against gram-positive pathogens isolated in the United States in 2000-2001A review of daptomycin for injection (Cubicin) in the treatment of complicated skin and skin structure infections.In vitro activities of daptomycin-, vancomycin-, and teicoplanin-loaded polymethylmethacrylate against methicillin-susceptible, methicillin-resistant, and vancomycin-intermediate strains of Staphylococcus aureus.Daptomycin.In vitro activities of a new lipopeptide, HMR 1043, against susceptible and resistant gram-positive isolatesDaptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens.Daptomycin susceptibility of unusual gram-positive bacteria: comparison of results obtained by the Etest and the broth microdilution method.Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).Modulation of the cellular accumulation and intracellular activity of daptomycin towards phagocytized Staphylococcus aureus by the P-glycoprotein (MDR1) efflux transporter in human THP-1 macrophages and madin-darby canine kidney cells.Daptomycin - a novel antibiotic against Gram-positive pathogens.Correlation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: revisiting daptomycin breakpoints.Inhibitors of reactive oxygen species accumulation delay and/or reduce the lethality of several antistaphylococcal agents.Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in TaiwanUpdate on daptomycin: the first approved lipopeptide antibiotic.Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections.Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections.Development of Tyrocidine A analogues with improved antibacterial activity.A current perspective on daptomycin for the clinical microbiologist.Pre-clinical experience with daptomycin.Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates.Pharmacodynamic evaluation of the activity of antibiotics against hemin- and menadione-dependent small-colony variants of Staphylococcus aureus in models of extracellular (broth) and intracellular (THP-1 monocytes) infections.In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates.Systematic evaluation of commercial susceptibility testing methods for determining the in vitro activity of daptomycin versus Staphylococcus aureus and Enterococci.Comparative efficacies of tedizolid phosphate, vancomycin, and daptomycin in a rabbit model of methicillin-resistant Staphylococcus aureus endocarditis.Rapid Turbidimetric Assay to Determine the Potency of Daptomycin in Lyophilized Powder.Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin.Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin.Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians.Evolution of high-level daptomycin resistance in Enterococcus faecium during daptomycin therapy is associated with limited mutations in the bacterial genome.Activity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infections.Comparative in vitro activities of nemonoxacin, doripenem, tigecycline and 16 other antimicrobials against Nocardia brasiliensis, Nocardia asteroides and unusual Nocardia species.Successful treatment of methicillin-resistant staphylococcus aureus meningitis with daptomycin.Daptomycin in vitro activity tested against Gram-positive strains collected from European and Latin American medical centers in 2003.
P2860
Q30586516-315DE5B3-DDDB-439B-96A0-8826856A5809Q33982424-D3DE51C8-992F-44E3-88E7-0CAC88298E3FQ34721715-2CBD0989-E619-423A-A6AE-A88058203D04Q34737651-D89AF83C-D809-457A-BBFC-313C223609E1Q34939045-A119F33F-8760-4A37-94AE-46DFC7E70780Q35166807-2B7588C6-2A64-4A52-97EC-74ED8859BE4FQ35598497-16C0EC53-720B-4E30-BF33-B6E58451CF33Q35637066-374716E4-564A-440A-A807-0EE3CDC5C49AQ35685332-2FA4AA88-98FD-4BE0-ABFB-91C5DD958C71Q35701450-7AEAACC1-0186-4E10-8356-7F5EFF6A87C9Q35758918-C3D75CFA-BEF4-4780-A50D-6D2AF31DD6BBQ35782816-41B42C31-5852-413D-A787-90AEB0D28BBBQ35912731-AC4FDE88-4379-4EC5-8669-FEA0CFED52EFQ35925535-137A8782-327D-4E38-9A7C-93CC42ED6596Q36171704-E010A21E-523F-4471-8E75-A20A81A48E15Q36364252-8CDAF833-78BE-4708-9F05-2646E1687D48Q36497876-CBC957E7-E7A3-4AE0-994D-E18DA391176AQ36521880-DE971B6D-585A-468F-9F2F-A3E9F9C2E2E7Q36718474-C82A2830-2417-40C4-A6FD-AE1947890547Q36777821-12270A18-F571-4198-92D9-622D0E0529A7Q37251382-386729D0-0FAD-4C28-AEFF-6F961C562B10Q37263289-3AB9F739-366F-4800-94A6-57C2D23E9270Q37284356-CB35155E-33FB-41D1-AE33-EFD06373847EQ38474869-5770B7E4-2B93-4955-B5AD-2A131416FEF2Q39352419-534EBCDC-A458-4451-9366-48CCE2E9CC23Q39730584-582E75AA-2F60-4122-AA3F-10B5AF526035Q40211359-74B5657B-DD3A-4CD5-96C6-A765D7E9AE3DQ40675142-B2D8E579-8E63-4765-9AAE-6ADF0C040D8CQ41610683-9F92E0FD-75D2-426A-B1DA-48A2D29CEE22Q41847350-F7394326-F46C-4E1C-AA61-05A0E89783E4Q42150957-03AE56B8-B348-4A51-8611-0ABC0D343E6BQ44579110-D249455F-3A8B-4CC9-9822-7B0E347F044CQ44602409-8116837C-CFB5-47CB-AEC5-5C6299C05077Q45226443-7A84C6A8-3C0B-4175-91D5-5D66A2C846FDQ46034503-CE33327E-8717-40E7-96D1-B809862706DEQ46476420-AF8874CC-2649-47E8-9832-64983B110E08Q46832044-C94E2BFF-5D1C-4276-8744-902749CEFB25
P2860
Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Daptomycin susceptibility test ...... of calcium on in vitro tests.
@en
Daptomycin susceptibility test ...... of calcium on in vitro tests.
@nl
type
label
Daptomycin susceptibility test ...... of calcium on in vitro tests.
@en
Daptomycin susceptibility test ...... of calcium on in vitro tests.
@nl
prefLabel
Daptomycin susceptibility test ...... of calcium on in vitro tests.
@en
Daptomycin susceptibility test ...... of calcium on in vitro tests.
@nl
P2093
P1476
Daptomycin susceptibility test ...... of calcium on in vitro tests.
@en
P2093
P356
10.1016/S0732-8893(00)00164-4
P577
2000-09-01T00:00:00Z